Searched for
VONOPRAZAN
Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...- Alkem inks licensing pact with Takeda to introduce Vonoprazan in IndiaAlkem Laboratories has entered into a patent licensing agreement with Takeda Pharmaceutical to market Vonoprazan in India. This medication ...
- Dr. Reddy’s Laboratories' board to consider stock split on July 27Dr. Reddy’s Laboratories' board will consider a stock split at the July 27 meeting. Last split was in 2001. Shares rose 17.5% this year, 27...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Mankind Pharma competes with EQT-ADIA combo for Rs 14,000 cr buyout of BSV Group from AdventThe buyout of BSV Group (formerly Bharat Serum & Vaccines Ltd) is contested by Mankind Pharma and EQT with ADIA, each offering around Rs 14...
- Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
- Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaMankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh st...
- Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in IndiaSun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- Torrent Pharma signs non-exclusive patent licensing pact with Takeda Pharma for VonoprazanA 2019 study published by the Indian Journal of Gastroenterology revealed that the prevalence of GERD in the Indian population is around 8....
Load More
